We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment.
- Authors
Yang, Ming-Hui; Ho, Tzu-Chuan; Chang, Chin-Chuan; Su, Yuh-Shan; Yuan, Cheng-Hui; Chuang, Kuo-Pin; Tyan, Yu-Chang
- Abstract
Two types of angiotensin-converting enzyme (ACE) inhibitors, lisinopril and benazepril HCl, were tested in neuroblastoma cells and found to upregulate low-density lipoprotein-receptor-related protein 1B (LRP1B) and 14-3-3 protein zeta/delta. Additionally, benazepril HCl was found to increase the expression of calreticulin. The upregulation of these proteins by ACE inhibitors may contribute to the amelioration of cognitive deficits in Alzheimer's disease/dementia, as well as the clinically observed deceleration of functional decline in Alzheimer's patients. This discovery suggests that the supplementation of ACE inhibitors may promote neuronal cell survival independently of their antihypertensive effect. Overall, these findings indicate that ACE inhibitors may be a promising avenue for developing effective treatments for Alzheimer's disease.
- Subjects
ALZHEIMER'S disease; ACE inhibitors; THERAPEUTICS; PROTEOMICS; ALZHEIMER'S patients; LISINOPRIL; ANGIOTENSIN converting enzyme; ANGIOTENSIN I
- Publication
Molecules, 2023, Vol 28, Issue 16, p5938
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules28165938